GDTC (CytoMed) Kacepetan wutah bathi saben saham ing taun lumaku
Growth for CytoMed Therapeutics (GDTC) is driven by progress in developing allogeneic tumor therapies and interest from big pharma. The annual EPS growth rate reflects current dynamics, with the figure fixed at 0.00. The strategy is based on the development of affordable CAR-T and CAR-NK drugs. Venture potential relies on early patents and the Singaporean platform, despite the risks associated with clinical stages.
Rincian analitis lan laporan data perusahaan w2.cytomed.sg (GDTC)
- rega saham lan target rega konsensus:
- indikator valuasi pasar bisnis:
- data ekuitas miturut neraca:
- indikator beban utang lan likuiditas:
Utang Agregat marang Modal CytoMed Therapeutics|GDTC - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal CytoMed Therapeutics Limited|GDTC - Utang perusahaan|Utang marang nilai buku CytoMed Therapeutics Limited|GDTC - Utang jangka dawa perusahaan|Utang jangka cendhak CytoMed Therapeutics|Rasio likuiditas darurat w2.cytomed.sg
- data bathi resik lan rasio valuasi:
GDTC - Penghasilan resik|Penghasilan resik sing dikarepake CytoMed Therapeutics|GDTC - Koefisien rega marang bathi|Rasio kapitalisasi marang bathi mangsa ngarep CytoMed Therapeutics Limited|GDTC - Pangali PEG|Nilai bisnis marang bathi operasional sadurunge panyusutan CytoMed Therapeutics Limited|GDTC - Bathi operasional EBITDA|Bathi resik saben siji saham sajrone rolas wulan pungkasan CytoMed Therapeutics|GDTC - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan w2.cytomed.sg|GDTC - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep CytoMed Therapeutics
- statistik dodolan lan pendapatan perusahaan:
Analisis dhasar perusahaan:GDTC, CytoMed
CytoMed Therapeutics (GDTC) focuses on expanding clinical trials in the field of cancer immunotherapy. This 12-month relative EPS growth indicator captures the percentage change in net profit per share compared to the previous year. The metric demonstrates the speed at which the market absorbs new business data, excluding emotional noise. The stability of management's scientific foundation directly influences the trajectory of this chart. Positive dynamics confirm capital resilience and the confidence of specialized funds.
Pesaing langsung
BeiGene Ltd. - Tambahing bathi saben saham ing taun lumaku|HALO (Halozyme Inc.) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Revolution Medicines Corp RVMD|Wutah bathi ing taun lumaku AAPG|Wutah bathi resik saben saham ing taun iki cgoncology.com CGON|UroGen Pharma - Wutah bathi resik saben saham ing taun iki|Bicara Therapeutics Inc (BCAX) - Kacepetan wutah bathi saben saham ing taun lumaku|PSNL: Wutah bathi resik saben saham ing taun iki|Erasca Oncology - Wutah bathi resik saben siji saham kanggo taun lumaku|Delcath Systems, Inc. (DCTH) - Wutah bathi saben saham ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku ymabs.com (YMAB)|Wutah bathi saben saham ing taun lumaku Aura Biosciences|Wutah bathi resik saben saham ing taun iki Candel (CADL)|Wutah bathi ing taun lumaku ARAY|SLS - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku ACTU (Actuate Therapeutics, Inc.)|CTOR: Wutah bathi saben saham ing taun iki|HURA: Wutah bathi resik saben saham ing taun iki|Tambahing bathi saben saham ing taun lumaku TARA (Protara Therapeutics Inc)|FATE (Fate Therapeutics Corp) - Wutah bathi resik saben saham ing taun iki|WHWK: Wutah bathi resik saben siji saham kanggo taun lumaku|TCRX (TScan Therapeutics Inc) - Wutah bathi ing taun lumaku|CSBR: Tambahing bathi saben saham ing taun lumaku|Wutah bathi ing taun lumaku XBIT|CVM - Kacepetan wutah bathi saben saham ing taun lumaku|Wutah bathi saben saham ing taun lumaku OS Therapies Inc OSTX|Tambahing bathi saben saham ing taun lumaku RADX|Artiva - Wutah bathi ing taun lumaku|ANL - Wutah bathi ing taun lumaku|Veru (VERU) - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham ing taun lumaku TPST (Tempest Therapeutics Inc)|XLO (Xilio Therapeutics Inc) - Wutah bathi ing taun lumaku|Kacepetan wutah bathi saben saham ing taun lumaku Enochian BioSciences RENB|Wutah bathi resik saben saham ing taun iki MURA (Mural Oncology plc)|Wutah bathi ing taun lumaku kairospharma.com (KAPA)|OnKure Therapeutics - Wutah bathi resik saben saham ing taun iki|Wutah bathi resik saben siji saham kanggo taun lumaku CRIS (Curis Inc.)|Apollomics Corp - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun iki Tharimmune Corporation THAR|ADVB: Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki genprex.com|Wutah bathi saben saham ing taun lumaku Calidi Biotherapeutics Inc.|sunshinebiopharma.com (SBFM) - Prakiraan wutah bathi resik saben saham ing taun iki|Wutah bathi ing taun lumaku XBIO|Salarius Pharma (SLRX) - Owah-owahan bathi resik saben saham ing taun lumaku|Wutah bathi ing taun lumaku PPBT (Purple Biotech)|AONC: Wutah bathi saben saham ing taun iki|BGNE: Wutah bathi resik saben saham ing taun iki|Checkpoint Therapeutics Inc. - Wutah bathi resik saben siji saham kanggo taun lumaku|ELEV: Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki iCAD|IKNA (Ikena Oncology Inc.) - Wutah bathi ing taun lumaku|Wutah bathi resik saben saham ing taun iki notablelabs.com (NTBL)|Wutah bathi ing taun lumaku VIRX|Wutah bathi ing taun lumaku MorphoSys Inc (MOR)|Wutah bathi saben saham ing taun lumaku NAYA Bio NAYA|AAPGV: Wutah bathi saben saham ing taun iki
